Deutsche Bank AG Acquires 4,350 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Deutsche Bank AG boosted its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 49.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,176 shares of the company’s stock after purchasing an additional 4,350 shares during the period. Deutsche Bank AG owned about 0.09% of U.S. Physical Therapy worth $1,169,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. D. E. Shaw & Co. Inc. grew its position in shares of U.S. Physical Therapy by 44.9% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 87,184 shares of the company’s stock worth $7,734,000 after buying an additional 27,028 shares during the last quarter. Cubist Systematic Strategies LLC purchased a new stake in U.S. Physical Therapy in the fourth quarter worth $586,000. Cetera Investment Advisers lifted its stake in U.S. Physical Therapy by 31.0% in the fourth quarter. Cetera Investment Advisers now owns 7,458 shares of the company’s stock worth $662,000 after acquiring an additional 1,763 shares during the period. Balyasny Asset Management L.P. boosted its holdings in U.S. Physical Therapy by 22.9% in the fourth quarter. Balyasny Asset Management L.P. now owns 9,453 shares of the company’s stock valued at $839,000 after acquiring an additional 1,759 shares in the last quarter. Finally, Baird Financial Group Inc. boosted its holdings in U.S. Physical Therapy by 16.7% in the fourth quarter. Baird Financial Group Inc. now owns 6,156 shares of the company’s stock valued at $546,000 after acquiring an additional 882 shares in the last quarter.

Analyst Upgrades and Downgrades

Several brokerages have commented on USPH. Wall Street Zen upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Thursday, May 8th. Barrington Research reduced their price target on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating on the stock in a research report on Friday, February 28th. William Blair reissued a “market perform” rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. JMP Securities reaffirmed a “market outperform” rating and set a $113.00 price objective on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. Finally, JPMorgan Chase & Co. reduced their target price on U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating on the stock in a report on Wednesday, March 19th. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $109.00.

Insiders Place Their Bets

In related news, COO Graham D. Reeve sold 1,730 shares of the stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the sale, the chief operating officer now directly owns 7,168 shares of the company’s stock, valued at approximately $588,564.48. This represents a 19.44% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 2.00% of the company’s stock.

U.S. Physical Therapy Stock Down 1.9%

NYSE:USPH opened at $73.96 on Monday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. The firm’s 50-day moving average price is $71.89 and its 200-day moving average price is $83.20. The company has a market capitalization of $1.12 billion, a PE ratio of 78.68, a P/E/G ratio of 3.54 and a beta of 1.44. U.S. Physical Therapy, Inc. has a 1-year low of $62.77 and a 1-year high of $102.89.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, beating analysts’ consensus estimates of $0.46 by $0.02. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The business had revenue of $183.79 million during the quarter, compared to the consensus estimate of $176.78 million. During the same quarter last year, the firm earned $0.51 earnings per share. The business’s revenue for the quarter was up 18.0% on a year-over-year basis. On average, equities analysts predict that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Friday, May 23rd will be paid a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a yield of 2.43%. The ex-dividend date is Friday, May 23rd. U.S. Physical Therapy’s payout ratio is 82.57%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.